Dexcom API nod from FDA

By Ricky Zipp writing for MedTechDive July 2021, “Dexcom wins FDA nod for real-time artificial pancreas systems (APIs), allowing third-party developers access to CGM data

Read More »

Dexcom delivering results 

Dexcom has presented promising results from two studies of continuous glucose monitors, including its next-generation G7 CGM, reports Drug Delivery Business. The first study –

Read More »